Lv72
4500 积分 2022-06-21 加入
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
12天前
已完结
Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase
23天前
已完结
Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for In Vivo Mouse Studies
1个月前
已完结
Application of Empirical Scalars To Enable Early Prediction of Human Hepatic Clearance Using In Vitro-In Vivo Extrapolation in Drug Discovery: An Evaluation of 173 Drugs
4个月前
已完结
5-HT 1A Agonists for levodopa-induced Dyskinesia in Parkinson’s Disease
5个月前
已完结
RNAi therapeutic and its innovative biotechnological evolution
6个月前
已完结
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
7个月前
已完结
A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia
9个月前
已完结
Enhancing GABA inhibition is the next generation of medications for essential tremor
9个月前
已完结
SR1375: Phase 1 results of a novel, orally administered lipoprotein‐associated phospholipase A2 inhibitor targeting diabetic macular oedema
10个月前
已关闭
皖公网安备34019202002308
